PCOR insider sales: O'Connor disposes 15,384 shares via 10b5-1
Rhea-AI Filing Summary
Kevin J. O'Connor, a director of Procore Technologies (PCOR), reported scheduled sales of company stock under a prearranged 10b5-1 plan. The filings show dispositions on 09/16/2025 and 09/17/2025: 7,692 shares sold at a weighted average price of $70.41 (range $70.05–$70.85), 7,255 shares sold at $72.55 (range $71.80–$72.775), and 437 shares sold at $72.93 (range $72.905–$72.955).
Following the transactions the filing reports indirect beneficial ownership maintained in the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19, with reported holdings of 1,131,021, then 1,123,766, then 1,123,329 shares after each sale. The Form 4 was signed by attorney-in-fact Benjamin C. Singer on 09/18/2025.
Positive
- Sales executed under a prearranged 10b5-1 plan, indicating scheduled, rule-compliant dispositions
- Transparent disclosure with weighted-average prices and price ranges for each tranche
Negative
- Insider dispositions reduced indirect holdings from 1,131,021 to 1,123,329 shares across the reported sales
- Materiality of the sales is unclear from the filing alone because the company's market capitalization and percent ownership impact are not provided
Insights
TL;DR Insider sales were executed under a prearranged 10b5-1 plan; transactions appear routine and disclosed with weighted-average pricing ranges.
The reported transactions total 15,384 shares sold across 09/16/2025–09/17/2025 in three tranches with weighted average prices of $70.41, $72.55 and $72.93. The filings show the shares are held indirectly in a revocable trust, and the sales reduced indirect holdings from 1,131,021 to 1,123,329 shares across the reported lines. From a trading-impact perspective, these are director-initiated dispositions under an established plan and documented with price ranges; there is no other transaction type or derivative activity reported.
TL;DR Sales were conducted via a disclosed 10b5-1 plan and properly reported on Form 4, indicating adherence to insider-trading protocols.
The filing explicitly states the disposals were made pursuant to a 10b5-1 plan dated November 21, 2024, and provides weighted-average price ranges and the trust holding details. The signature by an attorney-in-fact is included. These elements reflect standard governance procedures for scheduled insider sales and transparent SEC reporting; no unexplained amendments, option exercises, or derivative transactions accompany the disclosure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,255 | $72.55 | $526K |
| Sale | Common Stock | 437 | $72.93 | $32K |
| Sale | Common Stock | 7,692 | $70.41 | $542K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $70.05 to $70.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $71.80 to $72.775, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $72.905 to $72.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
